218 related articles for article (PubMed ID: 16153467)
1. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
[TBL] [Abstract][Full Text] [Related]
2. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
[TBL] [Abstract][Full Text] [Related]
3. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
[TBL] [Abstract][Full Text] [Related]
4. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.
Garnache-Ottou F; Feuillard J; Ferrand C; Biichle S; Trimoreau F; Seilles E; Salaun V; Garand R; Lepelley P; Maynadié M; Kuhlein E; Deconinck E; Daliphard S; Chaperot L; Beseggio L; Foisseaud V; Macintyre E; Bene MC; Saas P; Jacob MC;
Br J Haematol; 2009 Jun; 145(5):624-36. PubMed ID: 19388928
[TBL] [Abstract][Full Text] [Related]
5. [Hematodermic CD4+ CD56+ neoplasm in childhood].
Bilbao EA; Chirife AM; Florio D; Giménez LB; Marino L; Rosso DA
Medicina (B Aires); 2008; 68(2):147-50. PubMed ID: 18499965
[TBL] [Abstract][Full Text] [Related]
6. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
Herling M; Jones D
Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
[TBL] [Abstract][Full Text] [Related]
7. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement.
Stetsenko GY; McFarlane R; Kalus A; Olerud J; Cherian S; Fromm J; George E; Argenyi Z
J Cutan Pathol; 2008 Jun; 35(6):579-84. PubMed ID: 18005171
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous CD4+ CD56+ hematologic malignancies.
Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
[TBL] [Abstract][Full Text] [Related]
9. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.
Petrella T; Bagot M; Willemze R; Beylot-Barry M; Vergier B; Delaunay M; Meijer CJ; Courville P; Joly P; Grange F; De Muret A; Machet L; Dompmartin A; Bosq J; Durlach A; Bernard P; Dalac S; Dechelotte P; D'Incan M; Wechsler J; Teitell MA
Am J Clin Pathol; 2005 May; 123(5):662-75. PubMed ID: 15981806
[TBL] [Abstract][Full Text] [Related]
10. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases.
Ascani S; Massone C; Ferrara G; Rongioletti F; Papini M; Pileri S; Cerroni L
J Cutan Pathol; 2008 Oct; 35(10):911-5. PubMed ID: 18494823
[TBL] [Abstract][Full Text] [Related]
11. Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis.
Novak N; Allam JP; Hagemann T; Jenneck C; Laffer S; Valenta R; Kochan J; Bieber T
J Allergy Clin Immunol; 2004 Aug; 114(2):364-70. PubMed ID: 15316517
[TBL] [Abstract][Full Text] [Related]
12. CD4+/CD56+ hematodermic neoplasm: presentation of 2 cases and review of the concept of an uncommon tumor originated in plasmacytoid dendritic cells expressing CD123 (IL-3 receptor alpha).
Piña-Oviedo S; Herrera-Medina H; Coronado H; Del Valle L; Ortiz-Hidalgo C
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):481-6. PubMed ID: 18091395
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.
Ng AP; Lade S; Rutherford T; McCormack C; Prince HM; Westerman DA
Haematologica; 2006 Jan; 91(1):143-4. PubMed ID: 16434387
[TBL] [Abstract][Full Text] [Related]
14. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.
Jaye DL; Geigerman CM; Herling M; Eastburn K; Waller EK; Jones D
Mod Pathol; 2006 Dec; 19(12):1555-62. PubMed ID: 16998465
[TBL] [Abstract][Full Text] [Related]
15. Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells.
Gopcsa L; Banyai A; Jakab K; Kormos L; Tamaska J; Matolcsy A; Gogolak P; Rajnavolgyi E; Paloczi K
Eur J Haematol; 2005 Oct; 75(4):346-51. PubMed ID: 16146542
[TBL] [Abstract][Full Text] [Related]
16. Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge.
Ferran M; Gallardo F; Ferrer AM; Salar A; Pérez-Vila E; Juanpere N; Salgado R; Espinet B; Orfao A; Florensa L; Pujol RM
Br J Dermatol; 2008 May; 158(5):1129-33. PubMed ID: 18294313
[TBL] [Abstract][Full Text] [Related]
17. CD4+ CD56+ hematodermic neoplasm and plasmacytoid dendritic cell tumor: case report and review of the literature.
Campbell SM; Moad JC; Sammons DL; Zirwas M
Cutis; 2012 Jun; 89(6):278-83. PubMed ID: 22838092
[TBL] [Abstract][Full Text] [Related]
18. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
19. CD2- CD4+ CD56+ hematodermic/hematolymphoid malignancy.
Kato N; Yasukawa K; Kimura K; Sugawara H; Aoyagi S; Mishina T; Nakata T
J Am Acad Dermatol; 2001 Feb; 44(2):231-8. PubMed ID: 11174380
[TBL] [Abstract][Full Text] [Related]
20. A case of CD4+/CD56+ hematodermic neoplasm (plasmacytoid dendritic cell neoplasm).
Su O; Onsun N; Demirkesen C; Aydin Y; Pirmit S; Gereli M
Dermatol Online J; 2010 Apr; 16(4):8. PubMed ID: 20409415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
